WEBULL
News
MLAB
79.98
-0.61%
-0.49
Weekly Report: what happened at MLAB last week (1222-1226)?
Weekly Report · 21h ago
Weekly Report: what happened at MLAB last week (1215-1219)?
Weekly Report · 12/22 09:06
Mesa Laboratories Executives to Present at J.P. Morgan Healthcare Conference
Reuters · 12/19 00:00
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Barchart · 12/18 18:00
Mesa Labs Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 12/15 18:37
Mesa Labs Price Target Raised to $83.00/Share From $75.00 by Wells Fargo
Dow Jones · 12/15 18:37
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83
Benzinga · 12/15 18:27
Mesa Labs price target raised to $83 from $75 at Wells Fargo
TipRanks · 12/15 11:31
MESA LABORATORIES, INC. <MLAB.O>: WELLS FARGO RAISES TARGET PRICE TO $83 FROM $75
Reuters · 12/15 11:22
Weekly Report: what happened at MLAB last week (1208-1212)?
Weekly Report · 12/15 09:06
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 12/15 08:11
Weekly Report: what happened at MLAB last week (1201-1205)?
Weekly Report · 12/08 09:06
Mesa Laboratories Inc. to Announce Third Quarter Results
Reuters · 12/03 22:35
Weekly Report: what happened at MLAB last week (1124-1128)?
Weekly Report · 12/01 09:06
Here's Why Mesa Laboratories (NASDAQ:MLAB) Can Manage Its Debt Responsibly
Simply Wall St · 11/26 11:01
Mesa Laboratories: Appealing Territory Has Been Reached
Seeking Alpha · 11/25 06:05
Weekly Report: what happened at MLAB last week (1117-1121)?
Weekly Report · 11/24 09:06
Weekly Report: what happened at MLAB last week (1110-1114)?
Weekly Report · 11/17 09:06
Mesa Laboratories to Join Jefferies London Healthcare Conference
Reuters · 11/12 20:14
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
Barchart · 11/12 14:14
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.